Impact of the 2022 ATS/ERS update criteria on the bronchodilator responsiveness test result

Martins, B.; Marinho, A.; Amorim, Pedro

http://hdl.handle.net/10400.22/31116

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Carta ao editor_Pedro Amorim.pdf		542.17 KB	Adobe PDF	Download

Send Feedback

Authors

Martins, B.

Marinho, A.

Amorim, Pedro

Abstract(s)

Bronchodilator response (BDR) is a measurement of the degree of volume and airflow improvement in response to an inhaled short-acting bronchodilator. It is widely used in clinical practice to diagnose respiratory diseases such as chronic obstructive pulmonary disease (COPD) or asthma, to assess asthma control, and predict the response to inhaled treatment.

URI

http://hdl.handle.net/10400.22/31116

Citation

Martins, B., Marinho, A., & Amorim, P. (2024). Impact of the 2022 ATS/ERS update criteria on the bronchodilator responsiveness test result. Pulmonology, 30(6), 673–674. https://doi.org/10.1016/j.pulmoe.2024.06.003